Department of Clinical, Neuro- and Developmental Psychology, Faculty of Behavioral and Movement Sciences, Amsterdam Public Health institute, Vrije Universiteit Amsterdam, Van der Boechorststraat 7, 1081 BT, Amsterdam, The Netherlands.
Cancer Center Amsterdam (CCA), VU University Medical Center, De Boelelaan 1118, 1081 HV, Amsterdam, The Netherlands.
Support Care Cancer. 2019 Jul;27(7):2395-2412. doi: 10.1007/s00520-019-04764-7. Epub 2019 Apr 13.
The EORTC QLQ-CR29 is a patient-reported outcome measure to evaluate health-related quality of life among colorectal cancer patients in research and clinical practice. The aim of this systematic review was to investigate whether the initial positive results regarding the measurement properties of the QLQ-CR29 are confirmed in subsequent studies.
A systematic search of Embase, Medline, PsycINFO, and Web of Science was conducted to identify studies investigating the measurement properties of the QLQ-CR29 published up to January 2019. For the 11 included studies, data were extracted, methodological quality was assessed, results were synthesized, and evidence was graded according to the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) methodology on the measurement properties: structural validity, internal consistency, reliability, measurement error, construct validity (hypothesis testing, including known-group comparison, convergent and divergent validity), cross-cultural validity, and responsiveness.
Internal consistency was rated as "sufficient," with low evidence. Reliability was rated as "insufficient," with moderate evidence. Construct validity (hypothesis testing; known-group comparison, convergent and divergent validity) was rated as "inconsistent," with moderate evidence. Structural validity, measurement error, and responsiveness were rated as "indeterminate" and could therefore not be graded.
This review indicates that current evidence supporting the measurement properties of the QLQ-CR29 is limited. Additionally, better quality research is needed, taking into account the COSMIN methodology.
EORTC QLQ-CR29 是一种患者报告的结局测量工具,用于评估结直肠癌患者在研究和临床实践中的健康相关生活质量。本系统评价的目的是调查 QLQ-CR29 的测量特性的最初阳性结果是否在随后的研究中得到证实。
系统检索 Embase、Medline、PsycINFO 和 Web of Science,以确定截至 2019 年 1 月调查 QLQ-CR29 测量特性的研究。对于纳入的 11 项研究,提取数据,评估方法学质量,综合结果,并根据健康测量工具选择共识标准(COSMIN)方法学对测量特性进行证据分级:结构有效性、内部一致性、可靠性、测量误差、构念有效性(假设检验,包括已知组比较、收敛和发散有效性)、跨文化有效性和反应性。
内部一致性被评为“足够”,证据水平较低。可靠性被评为“不足”,证据水平中等。构念有效性(假设检验;已知组比较、收敛和发散有效性)被评为“不一致”,证据水平中等。结构有效性、测量误差和反应性被评为“不确定”,因此无法进行分级。
本综述表明,目前支持 QLQ-CR29 测量特性的证据有限。此外,需要更好质量的研究,同时考虑 COSMIN 方法学。